Madrigal Pharmaceuticals, Inc.

$83.46 0.00% ($0.00)

Get ready to invest

About Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. The Company’s lead product candidate, MGL-3196 (resmetirom), is a liver-directed, selective thyroid hormone receptor-ß (THR-ß) agonist for the treatment of non-alcoholic steatohepatitis (NASH)and heterozygous familial hypercholesterolemia (HeFH). Its product pipeline also includes MGL-3745, which is used in the treatment of NASH and HeFH.

Popular Stocks	Price	Change
Southwestern Energy SWN	$7.01 7.35%	7.35%
AMC AMC	$12.47 3.49%	3.49%
AMD AMD	$87.08 5.64%	5.64%
SoFi Technologies, Inc. SOFI	$6.13 6.06%	6.06%
ContextLogic WISH	$1.95 2.99%	2.99%
Bank of America BAC	$32.31 0.72%	0.72%
Apple AAPL	$141.66 2.45%	2.45%
Carnival CCL	$10.85 12.44%	12.44%
Amazon AMZN	$116.46 3.58%	3.58%
Ginkgo Bioworks Holdings DNA	$2.86 2.72%	2.72%